News Focus

Regulators Grapple With an Unorthodox Therapy

See allHide authors and affiliations

Science  30 Aug 2013:
Vol. 341, Issue 6149, pp. 956
DOI: 10.1126/science.341.6149.956

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


The rapid rise of fecal transplantation, coupled with pressure from enthusiastic patients and doctors, has regulators wondering how to respond. While European and Australian regulators have not yet stepped in, the U.S. Food and Drug Administration asserted its authority over the procedure in May—although it partially backtracked in July.

  • * Jop de Vrieze is a science writer in Amsterdam.

View Full Text

Stay Connected to Science